- Home
- GRYP vs KZIA Comparison
GRYP vs KZIA Comparison
Compare GRYP & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRYP
- KZIA
- Stock Information
- Founded
- GRYP 2010
- KZIA 1994
- Country
- GRYP United States
- KZIA Australia
- Employees
- GRYP N/A
- KZIA N/A
- Industry
- GRYP
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- GRYP
- KZIA Health Care
- Exchange
- GRYP Nasdaq
- KZIA Nasdaq
- Market Cap
- GRYP 18.0M
- KZIA 18.7M
- IPO Year
- GRYP N/A
- KZIA 1999
- Fundamental
- Price
- GRYP $0.38
- KZIA $3.18
- Analyst Decision
- GRYP Hold
- KZIA Strong Buy
- Analyst Count
- GRYP 1
- KZIA 1
- Target Price
- GRYP N/A
- KZIA $20.00
- AVG Volume (30 Days)
- GRYP 976.1K
- KZIA 77.0K
- Earning Date
- GRYP 11-13-2024
- KZIA 12-27-2024
- Dividend Yield
- GRYP N/A
- KZIA N/A
- EPS Growth
- GRYP N/A
- KZIA N/A
- EPS
- GRYP N/A
- KZIA N/A
- Revenue
- GRYP $22,783,000.00
- KZIA $1,655,324.00
- Revenue This Year
- GRYP N/A
- KZIA $806.89
- Revenue Next Year
- GRYP N/A
- KZIA N/A
- P/E Ratio
- GRYP N/A
- KZIA N/A
- Revenue Growth
- GRYP 14.06
- KZIA 248000.00
- 52 Week Low
- GRYP $0.38
- KZIA $1.90
- 52 Week High
- GRYP $10.30
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- GRYP 27.53
- KZIA 29.92
- Support Level
- GRYP $0.52
- KZIA $3.00
- Resistance Level
- GRYP $0.73
- KZIA $4.20
- Average True Range (ATR)
- GRYP 0.08
- KZIA 0.56
- MACD
- GRYP -0.03
- KZIA -0.15
- Stochastic Oscillator
- GRYP 0.76
- KZIA 5.82
About GRYP Gryphon Digital Mining Inc Common Stock
Gryphon Digital Mining Inc is a Bitcoin mining company. Gryphon's mission is to create the world's leading net carbon-neutral Bitcoin miner. The company will operate a digital asset, mining operation using specialized computers equipped with application-specific integrated circuit (ASIC) chips to solve complex cryptographic algorithms in support of the Bitcoin blockchain in exchange for cryptocurrency rewards (primarily Bitcoin).
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.